Averting the crisis in general practice through collaboration

Averting the crisis in general practice through collaboration

Chris Barker, Chief Executive of the Spirit Health Group, explores how to avert the crisis in general practice through collaboration. He believes a new...
Six steps to key account management in pharma

Six steps to key account management in pharma

David Southern and Gary Lunt outline six steps to key account management in pharma to enable the sector to adapt to complex and ever-changing...
Magnus Franzen on customer experience management

The art of customer experience management (CXM)

Magnus Franzen explains why customer experience management is essential to delivering what your customers need. Customer experience management (CXM) is both a discipline and a philosophy. “ACROSS...
Ben Osborn on transformation in the pharmaceutical industry

Transition and transformation in the pharmaceutical industry

Ben Osborn, Managing Director of Pfizer UK, talks transition and transformation in the pharmaceutical industry. Ben Osborn is the recently appointed Managing Director of Pfizer...
World networking showing how LinkedIn and the ABPI Code of Practice work together to connect professionals

The use of LinkedIn and the ABPI Code of Practice

Rina Newton, Managing Director of CompliMed, offers guidance on the use of LinkedIn and the ABPI Code of Practice. The Prescription Medicines Code of Practice Authority...
Mad on diving board jumping into pill pot depicting question does health trust pharma

Does health trust pharma? The results

Pf Magazine, along with E4H, set out to survey healthcare professionals about the level of trust they have in the pharmaceutical industry. This is...
Abbvie to acquire Allergan

Behaviour change on the frontline of pharma

Dr Pamela Walker discusses behaviour change on the frontline of pharma. Never before has pharmaceutical sales been as competitive or as complicated. Prescribers are often...

Understanding Multiple Sclerosis

[youtube https://www.youtube.com/watch?v=G7EE-Vz1O9Y&w=100&h=315]  Multiple sclerosis (MS) is a neurological condition affecting the central nervous system. ‘Sclerosis’ means the scarring or hardening of tiny patches of tissue;...

The UK as a global leader in antimicrobial resistance

Antimicrobial resistance in the UK: The need, the challenge & the way forward The Government wants the UK to become a leader in the development...
Rina Newton ABPI Code feedback

ABPI Code feedback

It has long been communicated to the UK pharmaceutical industry that the Prescription Medicines Code of Practice Authority (PMCPA) welcomes all input and feedback on...

Latest articles

Oral health has been isolated from traditional healthcare and health policy for too long fuelling an oral health crisis according to a Lancet Series.

Big Sugar and neglect by global health community fuel oral health crisis 

Oral health has been isolated from traditional healthcare and health policy for too long, despite the major global public health burden of oral diseases,...
New statistics show decrease in animals used for R&D

New statistics show decrease in animals used for R&D

The Home Office has released its annual statistics on animals used in research in Great Britain. It shows 3.52 million procedures were carried out...
New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford.

New insight into microRNA function can give gene therapy a boost

New insight into microRNA function has been published by scientists at the University of Eastern Finland and the University of Oxford. They have shown that...

Popular articles

pain relief patch released by nurofen

Nurofen launches a 24 hour ibuprofen pain relief patch

Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen.  Despite body pain being among the most commonly...
NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis.

Gene silencing therapy for hereditary amyloidosis approved by NICE

NICE has approved a first-in-class gene silencing therapy for hereditary amyloidosis. RNA interference (RNAi) therapeutics company, Alnylam UK Limited has welcomed a decision from the...
AstraZeneca to appeal NICE's osimertinib decision

AstraZeneca to appeal NICE’s osimertinib decision

AstraZeneca to appeal NICE's osimertinib decision following it not being recommended for use within NHS England. AstraZeneca will appeal a decision by the National Institute...

Top 5 R&D hubs in the UK

Read this cover story in the June issue of Pf Magazine here.    Join us on a tour of inspirational research and development centres. ...

How to write a standout CV

The job market is getting more competitive by the day, as highly-qualified candidates fiercely compete for the top jobs. A carefully constructed CV is...